MENU
+Compare
ARTL
Stock ticker: NASDAQ
AS OF
Dec 12 closing price
Price
$1.95
Change
+$0.01 (+0.52%)
Capitalization
3.94M

ARTL Artelo Biosciences Inc Forecast, Technical & Fundamental Analysis

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company... Show more

ARTL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ARTL with price predictions
Dec 11, 2025

ARTL's RSI Oscillator ascends from oversold territory

The RSI Indicator for ARTL moved out of oversold territory on November 28, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In of the 36 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 04, 2025. You may want to consider a long position or call options on ARTL as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ARTL just turned positive on November 14, 2025. Looking at past instances where ARTL's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARTL advanced for three days, in of 230 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 44 cases where ARTL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARTL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ARTL broke above its upper Bollinger Band on December 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ARTL entered a downward trend on December 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.834) is normal, around the industry mean (28.362). P/E Ratio (0.000) is within average values for comparable stocks, (51.986). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.836). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (336.196).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ARTL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ARTL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
505 Lomas Santa Fe
Phone
+1 858 925-7049
Employees
6
Web
https://www.artelobio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DIN34.040.19
+0.56%
Dine Brands Global
VTRS11.59-0.01
-0.09%
Viatris
MESO18.40-0.65
-3.41%
Mesoblast Limited
TOUR0.71-0.03
-4.22%
Tuniu Corp
KXIN3.88-0.32
-7.62%
Kaixin Holdings

ARTL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with NEVPF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTL
1D Price
Change %
ARTL100%
+2.11%
NEVPF - ARTL
35%
Loosely correlated
N/A
PALI - ARTL
34%
Loosely correlated
+4.76%
CRMD - ARTL
32%
Poorly correlated
+2.35%
FATE - ARTL
31%
Poorly correlated
+1.83%
PPBT - ARTL
30%
Poorly correlated
-0.45%
More